#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Acute promyelocytic leukaemia Glomerulonephritis Metastases to peritoneum Adrenocortical carcinoma Retinoblastoma Leiomyosarcoma metastatic Tourette's disorder Prodromal Alzheimer's disease Nasopharyngeal cancer Basal cell naevus syndrome KBG syndrome Immunodeficiency Crohn's disease Drug eruption Behcet's syndrome More trials…
Learn about Rare Diseases

Inclusion body myositis – Diagnostics Mucopolysaccharidosis III – Diagnostics Mitochondrial myopathy – Trials in Disease Angiosarcoma recurrent – Trials in Disease Cystic fibrosis – Trials in Disease Systemic mastocytosis – Treatment Factor VIII deficiency – Trials in Disease Lymphangiosarcoma – Life with Disease Angiosarcoma – Trials in Disease CADASIL More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Latozinemab Rbp030.2 ALENDRONATE SODIUM TRIHYDRATE Norepinephrine Mavacamten Pemetrexed Diacid Monohydrate SOFTISAN 378 Calcifediol [18F]Fapi-74 Vamorolone Mexiletine NERANDOMILAST Frexalimab Pegvaliase Secale Cereale Propranolol Hydrochloride Ngm707 Dexketoprofen GS-1720 Tremelimumab More therapies…

Learn about Your Condition

Osteosarcoma Labour pain Prostatitis Escherichia coli Drug dependence Extraskeletal ossification Metabolic disorder Lyme disease Breast conserving surgery Neurofibrosarcoma K-ras gene mutation Injection site pain Albuminuria Hepatobiliary disease Dystonic tremor Ebola disease More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Anaplastic lymphoma kinase gene mutation

Study Comparing Alectinib and Crizotinib for Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Anaplastic lymphoma kinase gene mutation
Investigated Drugs:
Study of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Anaplastic lymphoma kinase gene mutation
- Non-small cell lung cancer
Investigated Drugs:
+4

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Anaplastic lymphoma kinase gene mutation

Study Comparing Alectinib and Crizotinib for Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer

Study of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies